Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumabMartin Gunnarsson, Jan Lycke, Clas Malmeström et al.|Annals of Neurology|2010Cited by 347
Neurofilament and glial fibrillary acidic protein in multiple sclerosisNiklas Norgren, Martin Gunnarsson, Torgny Stigbrand et al.|Neurology|2004Cited by 245
Combined effects of smoking, anti-EBNA antibodies, and <i>HLA-DRB1*1501</i> on multiple sclerosis riskKG Simon, Alberto Ascherio, Peter Sundström et al.|Neurology|2010Cited by 133